The link between phenotype and fatty acid metabolism in advanced chronic kidney disease
- PMID: 28339984
- DOI: 10.1093/ndt/gfw415
The link between phenotype and fatty acid metabolism in advanced chronic kidney disease
Abstract
Background: The kidney plays a central role in elimination of metabolic waste products and regulation of low-molecular weight metabolites via glomerular filtration, tubular secretion and reabsorption. Disruption of these processes results in profound changes in the biochemical milieu of the body fluids, which contribute to complications of chronic kidney disease (CKD) by inducing cytotoxicity and inflammation. Insight into the changes of the composition of metabolites and dysregulation of target genes and proteins enhances the understanding of the pathophysiology of CKD and its complications, and the development of novel therapeutic strategies. Chronic interstitial nephropathy is a common cause of CKD. The present study was designed to determine the effect of chronic interstitial nephropathy on the composition of serum metabolites and regulation of oxidative, inflammatory, fibrotic and cytoprotective pathways.
Methods: Male Sprague-Dawley rats were randomized to the CKD and control groups ( n = 8/group). CKD was induced by administration of adenine (200 mg/kg body weight/day) by oral gavage for 3 weeks. The control group was treated with the vehicle alone. The animals were then observed for an additional 3 weeks, at which point they were sacrificed and kidney and serum samples were collected. Serum metabolomic and lipidomic analyses were performed using ultra-performance liquid chromatography-quadrupole time-of-flight high-definition mass spectrometry. Kidney tissues were processed for histological and molecular biochemical analyses.
Results: CKD rats exhibited increased plasma urea and creatinine concentrations, renal interstitial fibrosis, tubular damage and up-regulation of pro-inflammatory, pro-oxidant and pro-fibrotic pathways. Comparison of serum from CKD and control rats revealed significant differences in concentrations of amino acids and lipids including 33 metabolites and 35 lipid species. This was associated with marked abnormalities of fatty acid oxidation, and γ-linolenic acid and linoleic acid metabolism in CKD rats. Logistic regression analysis identified tetracosanoic acid, docosatrienoic acid, PC(18:3/14:1) and l -aspartic acid, tetracosanoic acid and docosatrienoic acid as novel biomarkers of chronic interstitial nephropathy.
Conclusions: Advanced CKD in rats with adenine-induced chronic interstitial nephropathy results in profound changes in the serum metabolome, activation of inflammatory, oxidative and fibrotic pathways, and suppression of cytoprotective and antioxidant pathways.
Keywords: chronic kidney disease; fatty acid oxidation; lipidomics; metabolomics; oxidative stress.
© The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
Similar articles
-
Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression.Redox Biol. 2016 Dec;10:168-178. doi: 10.1016/j.redox.2016.09.014. Epub 2016 Sep 28. Redox Biol. 2016. PMID: 27750081 Free PMC article.
-
Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis.Sci Rep. 2015 Sep 28;5:14472. doi: 10.1038/srep14472. Sci Rep. 2015. PMID: 26412413 Free PMC article.
-
Bupi Yishen formula may prevent kidney fibrosis by modulating fatty acid metabolism in renal tubules.Phytomedicine. 2023 Jun;114:154767. doi: 10.1016/j.phymed.2023.154767. Epub 2023 Mar 16. Phytomedicine. 2023. PMID: 37001297
-
Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease.Nat Rev Nephrol. 2022 Jan;18(1):38-55. doi: 10.1038/s41581-021-00488-2. Epub 2021 Oct 6. Nat Rev Nephrol. 2022. PMID: 34616096 Free PMC article. Review.
-
Metabolomics in chronic kidney disease.Clin Chim Acta. 2013 Jun 25;422:59-69. doi: 10.1016/j.cca.2013.03.033. Epub 2013 Apr 6. Clin Chim Acta. 2013. PMID: 23570820 Review.
Cited by
-
Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation.Front Pharmacol. 2021 Nov 15;12:761572. doi: 10.3389/fphar.2021.761572. eCollection 2021. Front Pharmacol. 2021. PMID: 34867380 Free PMC article.
-
Intestinal tract is an important organ for lowering serum uric acid in rats.PLoS One. 2017 Dec 21;12(12):e0190194. doi: 10.1371/journal.pone.0190194. eCollection 2017. PLoS One. 2017. PMID: 29267361 Free PMC article.
-
Lipid metabolism disorders and albuminuria risk: insights from National Health and Nutrition Examination Survey 2001-2018 and Mendelian randomization analyses.Ren Fail. 2024 Dec;46(2):2420841. doi: 10.1080/0886022X.2024.2420841. Epub 2024 Nov 3. Ren Fail. 2024. PMID: 39491271 Free PMC article.
-
Expression correlation attenuates within and between key signaling pathways in chronic kidney disease.BMC Med Genomics. 2020 Sep 21;13(Suppl 9):134. doi: 10.1186/s12920-020-00772-3. BMC Med Genomics. 2020. PMID: 32957963 Free PMC article.
-
Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network.BMC Complement Altern Med. 2018 Dec 20;18(1):340. doi: 10.1186/s12906-018-2395-2. BMC Complement Altern Med. 2018. PMID: 30572886 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical